| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.00032 | 1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.0002 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.00018 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.00022 | 1 |